Delivery Order SPE2DB20D2104-SPE2DB24FR10U

Award Date 11/9/23
Potential Completion Date 11/13/23
Potential Value $3.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,214.51, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,566,832,009 units of the pharmaceutical product Anastrozole 1 mg tablets, to be provided in 90-count bottles. The contract has a performance period ending on January 6, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count tablets of the medication Anastrozole 1 mg, with a ceiling value of $2,088.87 and a completion date of May 10, 2023. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,548.90, is for the delivery of 4560665798 Anastrozole 1 mg tablets in quantities of 90. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 21, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $1,791.12, is for the delivery of Anastrozole 1 mg Tablets in quantities of 90 per bottle. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,454.04 firm-fixed-price delivery order is for the supply of 90-count bottles of the drug Anastrozole 1 mg tablets. The contract has an ultimate completion date of January 24, 2023 and was awarded on January 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $28,608.26 firm fixed-price delivery order is for the supply of 4560913012 - Anastrozole 1 mg tablet 90s, with a performance period ending on May 12, 2023. The contract is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is a delivery order (SPE2DB24D2205|SPE2DB25FDXBZ) valued at $1,658.78, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of Anastrozole 1 mg tablets in 90-count packages, a medication used in the treatment of breast cancer. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Anastrozole 1 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $2,351.16 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 2, 2023, with a completion date of February 3, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award, with a $1,897.37 ceiling value, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4560137029 - ANASTROZOLE 1 MG TABLET 30S. There is no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999,...
This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,110.69 contract is for the supply of 30-count tablets of the drug Anastrozole 1 mg, a medication used to treat breast cancer. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FR10U
    Delivery Order

This federal contract award is for $3,153.71 and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,562,781,298 units of the medication Anastrozole 1 mg tablets in 30-count packages. The contract has an ultimate completion date of November 13, 2023 and was awarded on November 9, 2023.

This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract is not designated with any set-aside requirements.

AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. This parent-child relationship is reflected in the contract information provided. The DLA, as a defense agency, procures essential medical commodities to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 1:23 PM